Takeda Pharmaceutical Co Ltd (TKPHF) stock
TKPHFOTCPharmaceutical PreparationsAlso trades as TAK
$39.00+0.36 (+0.93%)
Close on Oct 19, 2026Market cap $134.41BP/E –Yield –
Takeda Pharmaceutical EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2026 it was -96.75 JPY, down 243.9% from the year before. The highest annual figure on record is 238.96 JPY in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -96.75 JPY | -243.9% |
| FY2025 | Mar 31, 2025 | 67.23 JPY | -26.3% |
| FY2024 | Mar 31, 2024 | 91.16 JPY | -54.9% |
| FY2023 | Mar 31, 2023 | 201.94 JPY | +38.4% |
| FY2022 | Mar 31, 2022 | 145.87 JPY | -39.0% |
| FY2021 | Mar 31, 2021 | 238.96 JPY | +745.9% |
| FY2020 | Mar 31, 2020 | 28.25 JPY | -79.8% |
| FY2019 | Mar 31, 2019 | 139.82 JPY | -41.1% |
| FY2018 | Mar 31, 2018 | 237.56 JPY | +62.4% |
| FY2017 | Mar 31, 2017 | 146.26 JPY | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics